Malaysian, Male, Aged 55
Lim Foo Seng was appointed to the Board on 1 February 2021.
He is a Member of the Malaysian Institute of Certified Public Accountants and the Malaysian Institute of Accountants.
He started his career at Deloitte Kassim Chan, an international accounting firm, from 1989 till 1995. Thereafter, he joined Arab-Malaysian Corporation Berhad (“Amcorp”) and left in 2003 where his last position was Chief Financial Officer (“CFO”) of MCM Technologies Berhad, a subsidiary company of Amcorp which was formerly listed on the then MESDAQ Market of Bursa Securities.
Subsequently, he joined Quest Technology Sdn Bhd (“Quest”) as CFO and from 2005 to 2008, he was Executive Director cum CFO for Quest’s immediate holding company, Ruby Quest Berhad, a company listed on the then MESDAQ Market of Bursa Securities. From 2008 to 2009, he was Executive Director of Asia Bioenergy Technologies Berhad, a company listed on the then MESDAQ Market of Bursa Securities. Between 2011 and 2013, he was Head of Strategic Planning for Aivoria Group Sdn Bhd and in 2014, he joined Winn Worldwide Sdn Bhd until 2017 as Chief Strategy Officer. In mid-2017, he joined Nova Pharma Solutions Berhad as Chief Strategy Officer, a company listed on the LEAP Market of Bursa Securities and left in mid-2023. He is currently the Executive Director and co-founder of Woodrose Healthcare Sdn Bhd, a company involved in elderly care services.
He was an Independent Non-Executive Director of Iskandar Waterfront City Berhad and Knusford Berhad, both listed on the Main Market of Bursa Securities from October 2013 and December 2013 respectively, until his retirement in October 2025 and December 2025.
He is also an Independent Non-Executive Director of PLS Plantations Berhad, a company listed on the Main Market of Bursa Securities.
He has no family relationship with any of the Directors and/or major shareholders.